Details for New Drug Application (NDA): 218565
✉ Email this page to a colleague
The generic ingredient in OSELTAMIVIR PHOSPHATE is oseltamivir phosphate. There are eight drug master file entries for this compound. Thirty-four suppliers are listed for this compound. Additional details are available on the oseltamivir phosphate profile page.
Summary for 218565
Tradename: | OSELTAMIVIR PHOSPHATE |
Applicant: | Laurus |
Ingredient: | oseltamivir phosphate |
Patents: | 0 |
Pharmacology for NDA: 218565
Mechanism of Action | Neuraminidase Inhibitors |
Medical Subject Heading (MeSH) Categories for 218565
Suppliers and Packaging for NDA: 218565
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
OSELTAMIVIR PHOSPHATE | oseltamivir phosphate | CAPSULE;ORAL | 218565 | ANDA | Laurus Labs Limited | 42385-985 | 42385-985-01 | 100 CAPSULE in 1 BOTTLE (42385-985-01) |
OSELTAMIVIR PHOSPHATE | oseltamivir phosphate | CAPSULE;ORAL | 218565 | ANDA | Laurus Labs Limited | 42385-985 | 42385-985-11 | 1 BLISTER PACK in 1 CARTON (42385-985-11) / 10 CAPSULE in 1 BLISTER PACK (42385-985-10) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | CAPSULE;ORAL | Strength | EQ 30MG BASE | ||||
Approval Date: | May 1, 2024 | TE: | AB | RLD: | No |
Profile for product number 002
Active Rx/OTC/Discontinued: | RX | Dosage: | CAPSULE;ORAL | Strength | EQ 45MG BASE | ||||
Approval Date: | May 1, 2024 | TE: | AB | RLD: | No |
Profile for product number 003
Active Rx/OTC/Discontinued: | RX | Dosage: | CAPSULE;ORAL | Strength | EQ 75MG BASE | ||||
Approval Date: | May 1, 2024 | TE: | AB | RLD: | No |
Complete Access Available with Subscription